Antibiotics usage in infants during the first 18 months of life in Benin: a population-based cohort study

A Brembilla1,2, F Mauny3,4, A Garcia5,6

  • 1Laboratoire Chrono-Environnement UMR CNRS 6249, Université Bourgogne Franche-Comté, 25000, Besançon, France. alice.brembilla@gmail.com.

Insights

Antibiotic prescriptions (ABPr) in African infants are common, especially for those over six months with respiratory or enteric symptoms. Malaria was linked to lower ABPr, highlighting the need for rational antibiotic use guidelines.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • Global health

Background:

  • Limited data exists on antibiotic usage patterns and determinants in African pediatric populations.
  • Understanding these factors is crucial for combating antimicrobial resistance.

Purpose of the Study:

  • To define the determinants of antibiotic prescriptions (ABPr) in a birth cohort of infants in Benin.
  • To identify key factors influencing antibiotic prescribing practices in this setting.

Main Methods:

  • A prospective birth cohort study followed 538 infants from birth to 18 months in three health centers (2007-2009).
  • Data collected included infant clinical findings, maternal/child characteristics, and general health parameters.
  • Multilevel logistic regression models were employed for data analysis.

Main Results:

  • Antibiotics were prescribed in 44.2% of 4394 consultations, with significant variation between health centers.
  • Nearly 40% of ABPr occurred in children without fever; rates were higher after six months of age.
  • Respiratory and enteric symptoms were associated with increased ABPr, while malaria was associated with decreased ABPr (OR=0.55).
  • Low breastfeeding scores were positively associated with ABPr.

Conclusions:

  • Antibiotic prescribing in Benin infants is influenced by age, symptoms (respiratory/enteric), and malaria status.
  • Interventions should target children over six months, those without malaria, and those with specific symptoms.
  • Further research is needed to improve healthcare provider adherence to antibiotic usage guidelines.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
Antibiotic Selection00:57

Antibiotic Selection

Overview
62.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
25
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
15